An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321

affy—analysis of Affymetrix GeneChip data at the probe level

Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,597

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,234

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863

BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion

Sethuraman, A., Brown, M., Krutilina, R., Wu, Z.-H., Seagroves, T. N., Pfeffer, L. M., & Fan, M. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1046-3 · Cited by 63

Identifying Cancers Impacted by CDK8/19

Roninson, I. B., Győrffy, B., Mack, Z. T., Shtil, A. A., Shtutman, M. S., Chen, M., & Broude, E. V. (2019) · Cells · doi:10.3390/cells8080821 · Cited by 63

WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling

Jiang, S., Zhang, M., Zhang, Y., Zhou, W., Zhu, T., Ruan, Q., Chen, H., Fang, J., Zhou, F., Sun, J., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0419-2 · Cited by 64

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Bhat‐Nakshatri, P., Goswami, C. P., Badve, S., Sledge, G. W., & Nakshatri, H. (2013) · Scientific Reports · doi:10.1038/srep02530 · Cited by 65

Nuclear pore protein NUP210 depletion suppresses metastasis through heterochromatin-mediated disruption of tumor cell mechanical response

Amin, R., Shukla, A., Zhu, J. J., Kim, S., Wang, P., Tian, S. Z., Tran, A. D., Paul, D., Cappell, S. D., Burkett, S. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27451-w · Cited by 62

c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer

He, H., Sinha, I., Fan, R., Haldosén, L.-A., Yan, F., Zhao, C., & Dahlman‐Wright, K. (2018) · Oncogene · doi:10.1038/s41388-018-0165-8 · Cited by 62

Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets

Gates, L. A., Gu, G., Chen, Y., Rohira, A. D., Lei, J. T., Hamilton, R. A., Yu, Y., Lonard, D. M., Wang, J., Wang, S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0284-2 · Cited by 65

Targeting SLC25A10 alleviates improved antioxidant capacity and associated radioresistance of cancer cells induced by chronic-cycling hypoxia

Hlouschek, J., Ritter, V., Wirsdörfer, F., Klein, D., Jendrossek, V., & Matschke, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.002 · Cited by 66

Integrated analyses of murine breast cancer models reveal critical parallels with human disease

Rennhack, J. P., To, B., Swiatnicki, M., Dulak, C., Ogrodzinski, M. P., Zhang, Y., Li, C., Bylett, E., Ross, C. R., Szczepanek, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11236-3 · Cited by 66

Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway

Brindisi, M., Fiorillo, M., Frattaruolo, L., Sotgia, F., Lisanti, M. P., & Cappello, A. R. (2020) · Cells · doi:10.3390/cells9081819 · Cited by 62

Hotspot mutant p53-R273H inhibits KLF6 expression to promote cell migration and tumor metastasis

Sun, S., Chen, H., Sun, L., Wang, M., Wu, X., & Xiao, Z. J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02814-1 · Cited by 61

Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1α Translation in Triple-Negative Breast Cancer

Du, Y., Wei, N., Ma, R., Jiang, S., & Song, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.580176 · Cited by 61

Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: A comprehensive analysis

Mehraj, U., Aisha, S., Sofi, S., & Mir, M. A. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100037 · Cited by 58

Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer

Fan, M., Sethuraman, A., Brown, M., Sun, W., & Pfeffer, L. M. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3040-5 · Cited by 62

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value

Cohen, P. A., Donini, C. F., Nguyen, N. T., Lincet, H., & Vendrell, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.5893 · Cited by 60

Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition

Ye, L., Guo, L., He, Z., Wang, X., Lin, C., Zhang, X., Wu, S., Bao, Y., Yang, Q., Song, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8121 · Cited by 61

Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition

Halldórsson, S., Rohatgi, N., Magnúsdóttir, M., Choudhary, K. S., Guðjónsson, Þ., Knutsen, E., Barkovskaya, A., Hilmarsdóttir, B., Perander, M., Mælandsmo, G. M., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.019 · Cited by 60

Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α

Dou, X., Liang, Y., Lin, H., Wei, X., Zhang, Y., Bai, J., Chen, C., Chen, M., Du, C., Li, Y., et al. (2017) · Theranostics · doi:10.7150/thno.19989 · Cited by 62

USP11 Enhances TGFβ-Induced Epithelial–Mesenchymal Plasticity and Human Breast Cancer Metastasis

Garcia, D. A., Baek, C., Estrada, M. V., Tysl, T., Bennett, E. J., Yang, J., & Chang, J. T. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0723 · Cited by 62

FOXP3 inhibits angiogenesis by downregulating VEGF in breast cancer

Li, X., Gao, Y., Li, J., Zhang, K., Han, J., Li, W., Hao, Q., Zhang, W., Wang, S., Zeng, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0790-8 · Cited by 64

PSMB5 plays a dual role in cancer development and immunosuppression.

Wang, C., Li, C.-Y., Hsu, H., Cho, C.-Y., Yen, M., Weng, T., Chen, W.-C., Hung, Y.-H., Lee, K. T., Hung, J., et al. (2017) · Europe PMC (PubMed Central) · Cited by 60

SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation

Gomez-Jenkins, M., Shah, N., Kenny, T. C., Jenkins, E. C., & Germain, D. (2019) · Oncogene · doi:10.1038/s41388-019-0839-x · Cited by 61

EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis

Huang, C., Hu, F., Song, D., Sun, X., Liu, A., Wu, Q., She, X., Chen, Y., Chen, L., Hu, F., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci152394 · Cited by 61

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment

Araujo, A. M., Abaurrea, A., Azcoaga, P., López-Velazco, J. I., Manzano, S., Rodríguez, J., Rezola, R., Egia‐Mendikute, L., Valdés‐Mora, F., Flores, J. M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148667 · Cited by 62

MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms

Chi, L. H., Cross, R. S., Redvers, R. P., Davis, M. J., Hediyeh-zadeh, S., Mathivanan, S., Samuel, M., Lucas, E. C., Mouchemore, K. A., Gregory, P. A., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00413-7 · Cited by 68

TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer

Singha, P. K., Pandeswara, S., Geng, H. Z., Lan, R., Venkatachalam, M. A., & Saikumar, P. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.30 · Cited by 61

PRMT2 and RORγ Expression Are Associated With Breast Cancer Survival Outcomes

Oh, T. G., Bailey, P. J., Dray, E. V., Smith, A. G., Goode, J. M., Eriksson, N. A., Funder, J. W., Fuller, P. J., Simpson, E. R., Tilley, W. D., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1403 · Cited by 61

Germline PARP4 mutations in patients with primary thyroid and breast cancers

Ikeda, Y., Kiyotani, K., Yew, P. Y., Kato, T., Tamura, K., Yap, K. L., Nielsen, S. M., Mester, J. L., Eng, C., Nakamura, Y., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0359 · Cited by 64

Hypoxic pathobiology of breast cancer metastasis

Schito, L., & Rey, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.004 · Cited by 63

Targeting bromodomain and extraterminal proteins in breast cancer

Sahni, J. M., & Keri, R. A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.015 · Cited by 61

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment

Austin, D., Hamilton, N. M., Elshimali, Y., Pietras, R. J., Wu, Y., & Vadgama, J. V. (2018) · Oncotarget · doi:10.18632/oncotarget.26089 · Cited by 60

Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca2+-NFAT1 Axis

Chen, X., Cao, Q., Liao, R., Wu, X., Xun, S., Huang, J., & Dong, C. (2018) · Theranostics · doi:10.7150/thno.29407 · Cited by 61

Deregulating the CYP2C19/Epoxy-Eicosatrienoic Acid-Associated FABP4/FABP5 Signaling Network as a Therapeutic Approach for Metastatic Triple-Negative Breast Cancer

Apaya, M. K., Hsiao, P., Yang, Y., & Shyur, L. (2020) · Cancers · doi:10.3390/cancers12010199 · Cited by 60

ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancers

Wang, W., Li, M., Ponnusamy, S., Chi, Y., Xue, J., Fahmy, B., Fan, M., Miranda‐Carboni, G. A., Narayanan, R., Wu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17770-9 · Cited by 64

The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer – New Combinational Approaches and Strategies of Neovessel Inhibition

Daum, S., Hagen, H., Naismith, E., Wolf, D. G. F., & Pircher, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.610903 · Cited by 60

The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion

Maine, E. A., Westcott, J. M., Prechtl, A. M., Dang, T. T., Whitehurst, A. W., & Pearson, G. W. (2016) · Oncotarget · doi:10.18632/oncotarget.7408 · Cited by 59

UDP-glucose 6-dehydrogenase regulates hyaluronic acid production and promotes breast cancer progression

Arnold, J. M., Gu, F., Ambati, C. R., Rasaily, U., Ramirez‐Peña, E., Joseph, R., Manikkam, M., Martin, R. S., Charles, C., Pan, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0885-4 · Cited by 59

Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters

Sudhakaran, M., Parra, M. R., Stoub, H., Gallo, K. A., & Doseff, A. I. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114259 · Cited by 60

Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 + and CD8 + T‐cell protective responses to breast cancer

Mattiuz, R., Brousse, C., Ambrosini, M., Cancel, J.-C., Bessou, G., Mussard, J., Sanlaville, A., Caux, C., Bendriss‐Vermare, N., Valladeau‐Guilemond, J., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1305 · Cited by 61

A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples

Zwart, W. T., Koornstra, R. H. T., Wesseling, J., Rutgers, E. J. T., Linn, S. C., & Carroll, J. S. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-232 · Cited by 59

A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion

Dai, M., Al-Odaini, A. A., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3322 · Cited by 61

Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer

Xu, S., Zhang, J., Sui, S., Bai, N.-X., Gao, S., Zhang, G., Shi, Q.-Y., You, Z., Zhan, C., & Pang, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-3746-y · Cited by 59

Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17

Hu, D. G., Selth, L. A., Tarulli, G. A., Meech, R., Wijayakumara, D., Chanawong, A., Russell, R., Caldas, C., Robinson, J. L. L., Carroll, J. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3372 · Cited by 59

IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21

Lui, A. J., Geanes, E. S., Ogony, J. W., Behbod, F., Marquess, J., Valdez, K. E., Jewell, W. R., Tawfik, O. W., & Lewis-Wambi, J. S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.005 · Cited by 59

Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma

Huang, Y., Ning, G., Chen, L., Lian, Y., Gu, Y., Wang, J., Chen, D., Wei, H. J., & Huang, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s182001 · Cited by 57

MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3

Long, X., Shi, Y. H., Ye, P., Guo, J., Zhou, Q., & Tang, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01473 · Cited by 58

TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer

Bianchi, F., Alexiadis, S., Camisaschi, C., Truini, M., Centonze, G., Milione, M., Balsari, A., Tagliabue, E., & Sfondrini, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041440 · Cited by 59

Identification of Nidogen 1 as a lung metastasis protein through secretome analysisPreprint

Alečković, M., Wei, Y., LeRoy, G., Sidoli, S., Liu, D. D., Garcia, B. A., & Kang, Y. (2017) · Genes & Development · doi:10.1101/gad.301937.117 · Cited by 60

PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome

Antonov, A. V., Krestyaninova, M., Knight, R. A., Rodchenkov, I. V., Melino, G., & Barlev, N. A. (2013) · Oncogene · doi:10.1038/onc.2013.119 · Cited by 58

UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer

Chen, X.-S., Wang, K.-S., Guo, W., Li, L.-Y., Yu, P., Sun, X.-Y., Wang, H.-Y., Guan, Y.-D., Tao, Y.-G., Ding, B.-N., et al. (2020) · Theranostics · doi:10.7150/thno.39814 · Cited by 58

Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer

Zhao, W., Wang, M., Cai, M., Zhang, C.-H., Qiu, Y., Wang, X., Zhang, T., Zhou, H., Wang, J., Zhao, W., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110956 · Cited by 58

NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT

Nakshatri, H., Appaiah, H. N., Anjanappa, M., Gilley, D. P., Tanaka, H., Badve, S., Crooks, P. A., Mathews, W. P., Sweeney, C. J., & Bhat‐Nakshatri, P. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.569 · Cited by 58

Loss of CLCA4 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer Cells

Yu, Y., Walia, V., & Elble, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083943 · Cited by 58

AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathway

Hrstka, R., Bouchalová, P., Michalová, E., Matoulková, E., Müller, P., Coates, P. J., & Vojtěšek, B. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.003 · Cited by 60

The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis

Zu, L., Xue, Y., Wang, J., Fu, Y., Wang, X., Xiao, G., Hao, M., Sun, X., Wang, Y., Fu, G., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw011 · Cited by 58

miR‑27a promotes human breast cancer cell migration by inducing EMT in a FBXW7‑dependent manner

Jiang, G., Shi, W., Fang, H., & Zhang, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9587 · Cited by 59

The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells

Luo, M., Li, J., Shen, L., Chu, J., Guo, Q., Liang, G., Wu, W., Chen, J., Chen, R., & Song, E. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz134 · Cited by 58

O-GlcNAc Transferase Regulates Cancer Stem–like Potential of Breast Cancer Cells

Akella, N. M., Minh, G. L., Ciraku, L., Mukherjee, A., Bacigalupa, Z. A., Mukhopadhyay, D., Sodi, V. L., & Reginato, M. J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0732 · Cited by 62

Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors

Labidi‐Galy, S. I., Clauss, A., Ng, V., Duraisamy, S., Elias, K. M., Piao, H.-Y., Bilal, E., Davidowitz, R. A., Lu, Y., Badalian‐Very, G., et al. (2014) · Oncogene · doi:10.1038/onc.2013.562 · Cited by 57

An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells

Baran‐Gale, J., Purvis, J. E., & Sethupathy, P. (2016) · RNA · doi:10.1261/rna.056895.116 · Cited by 61

Overexpression of CDCA7 predicts poor prognosis and induces EZH2‐mediated progression of triple‐negative breast cancer

Ye, L., Li, F., Song, Y., Yu, D., Xiong, Z., Li, Y., Shi, T., Yuan, Z., Lin, C., Wu, X., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31766 · Cited by 57

The prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis

Almeida, M., Soares, M., Ramalhinho, A. C., Fonseca-Moutinho, J. A., Breitenfeld, L., & Pereira, L. C. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05494-4 · Cited by 57

The NFIB‐ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells

Zilli, F., Ramos, P. M., der Maur, P. A., Jehanno, C., Sethi, A., Coissieux, M., Eichlisberger, T., Sauteur, L., Rouchon, A., Bonapace, L., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013162 · Cited by 57

IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer

Ka, N., Lim, G. Y., Hwang, S., Kim, S.-S., & Lee, M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110138 · Cited by 61

Metabolic Profiling Reveals PAFAH1B3 as a Critical Driver of Breast Cancer Pathogenicity

Mulvihill, M. M., Benjamin, D. I., Ji, X., Scolan, E. L., Louie, S. M., Shieh, A., Green, M., Narasimhalu, T., Morris, P. J., Luo, K., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.05.008 · Cited by 57

HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2

Cheng, G., Sun, X., Wang, J., Xiao, G., Fan, X., Fan, X., Zu, L., Hao, M., Qu, Q., Mao, Y., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2420 · Cited by 57

PRMT8 demonstrates variant-specific expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer

Hernandez, S. J., Dolivo, D., & Dominko, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.5671 · Cited by 57

Breast cancer cell adhesome and degradome interact to drive metastasis

Rizwan, A., Cheng, M., Bhujwalla, Z. M., Krishnamachary, B., Jiang, L., & Glunde, K. (2015) · npj Breast Cancer · doi:10.1038/npjbcancer.2015.17 · Cited by 57

DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-Myb acetylation upon matrix stiffening

Kim, D., You, E., Jeong, J., Ko, P., Kim, J.-W., & Rhee, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07126-7 · Cited by 57

ESR1 -Stabilizing Long Noncoding RNA TMPO-AS1 Promotes Hormone-Refractory Breast Cancer Progression

Mitobe, Y., Ikeda, K., Suzuki, T., Takagi, K., Kawabata, H., Horie‐Inoue, K., & Inoue, S. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00261-19 · Cited by 58

MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway

Yao, L., Wu, L., Zhang, L., Zhou, W., Wu, L., He, K., Ren, J., Deng, Y., Yang, D., Wang, J., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0198-z · Cited by 58

Proteins with Evolutionarily Hypervariable Domains are Associated with Immune Response and Better Survival of Basal-like Breast Cancer Patients

Xu, S., Yuan, F., & Zhao, S. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.03.008 · Cited by 56

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy

Bao, Y., Oguz, G., Lee, W. C., Lee, P. L., Ghosh, K., Li, J., Wang, P., Lobie, P. E., Ehmsen, S., Ditzel, H. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19704-x · Cited by 58

The cell cycle‐related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients

Kahl, I., Mense, J., Finke, C., Boller, A.-L., Lorber, C., Győrffy, B., Greve, B., Götte, M., & Espinoza‐Sánchez, N. A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30205 · Cited by 56

Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer

Adam‐Artigues, A., Arenas, E. J., Martínez, A., Brasó‐Maristany, F., Cervera, R., Tormo, E., Hernándo, C., Martínez, M. T., Carbonell‐Asins, J. A., Simón, S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk2746 · Cited by 57

NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma

Su, B.-H., Qu, J., Song, M. S., Huang, X., Hu, X.-M., Xie, J. W., Zhao, Y., Ding, L.-C., She, L., Chen, J., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2321 · Cited by 57

MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer

Ujihira, T., Ikeda, K., Suzuki, T., Yamaga, R., Sato, W., Horie‐Inoue, K., Shigekawa, T., Osaki, A., Saeki, T., Okamoto, K., et al. (2015) · Scientific Reports · doi:10.1038/srep07641 · Cited by 56

Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models

Li, Y., Drabsch, Y., Pujuguet, P., Ren, J., van Laar, T., Zhang, L., van Dam, H., Clément-Lacroix, P., & ten Dijke, P. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0537-8 · Cited by 58

A siRNA screen identifies RAD21 , EIF3H , CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation

Mahmood, S. F., Gruel, N., Chapeaublanc, E., Lescure, A., Jones, T. R., Reyal, F., Vincent‐Salomon, A., Raynal, V., Pierron, G., Perez, F., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt351 · Cited by 56

Synaptopodin‐2 suppresses metastasis of triple‐negative breast cancer via inhibition of YAP/TAZ activity

Liu, J., Ye, L., Li, Q., Wu, X., Wang, B., Ouyang, Y., Yuan, Z., Li, J., & Lin, C. (2017) · The Journal of Pathology · doi:10.1002/path.4995 · Cited by 56

Increased α-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer

Kovac, B., Mäkelä, T. P., & Vallenius, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196986 · Cited by 56

Opposing Regulation of Cancer Properties via KRT19-Mediated Differential Modulation of Wnt/β-Catenin/Notch Signaling in Breast and Colon Cancers

Saha, S. K., Yin, Y., Chae, H. S., & Cho, S. (2019) · Cancers · doi:10.3390/cancers11010099 · Cited by 60

Host CYP27A1 expression is essential for ovarian cancer progression.

He, S.-S., Ma, L., Baek, A., Vardanyan, A., Vembar, V., Chen, J. J., Nelson, A. T., Burdette, J. E., & Nelson, E. R. (2019) · Endocrine-Related Cancer · doi:10.1530/erc-18-0572 · Cited by 49

Estrogen receptor-mediated targeting of the extracellular matrix network in cancer

Piperigkou, Z., & Karamanos, N. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.006 · Cited by 56

Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer

Noureddine, L. M., Trédan, O., Hussein, N., Badran, B. M., Romancer, M. L., & Poulard, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094446 · Cited by 58

Fibulin-2 is required for basement membrane integrity of mammary epithelium

Ibrahim, A. M., Sabet, S., El-Ghor, A. A., Kamel, N. N., Anis, S. E., Morris, J. S., & Stein, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-32507-x · Cited by 55

Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways

Xie, C., Mondal, D. K., Ulas, M., Neill, T., & Iozzo, R. V. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00016.2022 · Cited by 57

Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer

Ren, Z., Liang, H., Galbo, P. M., Dharmaratne, M., Kulkarni, A. S., Fard, A. T., Aoun, M. L., Martínez-López, N., Suyama, K., Benard, O., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107266119 · Cited by 57

OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor

Fan, C., Wang, Q., van der Zon, G., Ren, J., Agaser, C., Slieker, R. C., Iyengar, P. V., Mei, H., & ten Dijke, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00944-w · Cited by 55

Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells

Burnett, R. M., Craven, K. E., Krishnamurthy, P., Goswami, C. P., Badve, S., Crooks, P. A., Mathews, W. P., Bhat‐Nakshatri, P., & Nakshatri, H. (2015) · Oncotarget · doi:10.18632/oncotarget.3707 · Cited by 55

Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers

Sengupta, S., Biarnes, M. C., & Jordan, V. C. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2789-2 · Cited by 56

Proteomic Signatures of Acquired Letrozole Resistance in Breast Cancer: Suppressed Estrogen Signaling and Increased Cell Motility and Invasiveness

Tilghman, S. L., Townley, I. K., Zhong, Q., Carriere, P. P., Zou, J., Llopis, S. D., Preyan, L. C., Williams, C. C., Skripnikova, E., Bratton, M. R., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.023861 · Cited by 56

Integrins synergise to induce expression of the MRTF-A–SRF target gene ISG15 for promoting cancer cell invasion

Hermann, M.-R., Jakobson, M., Coló, G. P., Rognoni, E., Jakobson, M., Kupatt, C., Posern, G., & Fässler, R. (2016) · Journal of Cell Science · doi:10.1242/jcs.177592 · Cited by 55

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer

Tomiguchi, M., Yamamoto, Y., Yamamoto‐Ibusuki, M., Goto‐Yamaguchi, L., Fujiki, Y., Fujiwara, S., Sueta, A., Hayashi, M., Takeshita, T., Inao, T., et al. (2016) · Cancer Science · doi:10.1111/cas.12897 · Cited by 55

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis

Su, J.-C., Mar, A.-C., Wu, S., Tai, W., Chu, P., Wu, C.-Y., Tseng, L., Lee, T., Chen, K., Liu, C., et al. (2016) · Scientific Reports · doi:10.1038/srep28888 · Cited by 54

CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target

Binothman, N., Hachim, I. Y., Lebrun, J. J., & Ali, S. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.06.023 · Cited by 55

Noncanonical agonist PPARγ ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy

Khandekar, M. J., Banks, A. S., Laznik-Bogoslavski, D., White, J. P., Choi, J. H., Kazak, L., Lo, J. C., Cohen, P., Wong, K., Kamenecka, T. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717776115 · Cited by 55

Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors

Delaney, J. R., Patel, C. B., Bapat, J., Jones, C. M., Zapatero, M. R., Ortell, K. K., Tanios, R., Haghighiabyaneh, M., Axelrod, J. L., DeStefano, J., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008558 · Cited by 57

MAGI2‐AS3 inhibits breast cancer by downregulating DNA methylation of MAGI2

Xu, X., Yuan, X., Ni, J., Guo, J., Gao, Y., Yin, W., Li, F., Wei, L., & Zhang, J. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29922 · Cited by 55

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment

Alcaraz, L. B., Mallavialle, A., David, T., Derocq, D., Delolme, F., Dieryckx, C., Mollévi, C., Boissière‐Michot, F., Simony-Lafontaine, J., du Manoir, S., et al. (2021) · Theranostics · doi:10.7150/thno.58254 · Cited by 54

P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p1-07-18 · Cited by 70

Online biomarker validation of survival-associated biomarkers in breast and ovarian cancer using microarray data of 3,862 patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.10571

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 2,024

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

van Laar, R. K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.003 · Cited by 12

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Jézéquel, P., Campone, M., Gouraud, W., Guérin‐Charbonnel, C., Leux, C., Ricolleau, G., & Campion, L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1457-7 · Cited by 410